IMRT 2018

First page Table of contents Previous page 525 Next page Last page

Hodgkin’s Disease – Stanford Clinical Trial: Stage I-IIA IF vs (S)TLI

RT dose: 40 Gy

Made with FlippingBook - professional solution for displaying marketing and sales documents online